Free Trial

DiaMedica Therapeutics (DMAC) SEC Filings & 10K Form

DiaMedica Therapeutics logo
$4.43
0.00 (0.00%)
(As of 03:56 PM ET)

Recent DiaMedica Therapeutics SEC Filings

DateFilerForm TypeView
08/07/2024
3:31 PM
DiaMedica Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:32 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
11:15 PM
DiaMedica Therapeutics (Filer)
Form EFFECT
07/18/2024
4:28 PM
DiaMedica Therapeutics (Filer)
Form 424B3
07/10/2024
3:16 PM
DiaMedica Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/08/2024
4:23 PM
DIALECTIC CAPITAL MANAGEMENT, LP (Filed by)
DiaMedica Therapeutics (Subject)
Form SC 13G
07/02/2024
1:25 PM
Daves Julie VanOrsdel (Reporting)
DiaMedica Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:24 PM
DiaMedica Therapeutics (Issuer)
STAHLBERG JAN (Reporting)
TRILL AB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
7:16 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
7:01 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
3:41 PM
DiaMedica Therapeutics (Issuer)
Pauls Dietrich John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:29 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:35 PM
DiaMedica Therapeutics (Issuer)
Semba Charles Pauling (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:09 PM
DiaMedica Therapeutics (Issuer)
Kuntz Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:14 PM
DiaMedica Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:36 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
11:15 PM
DiaMedica Therapeutics (Filer)
Form EFFECT
04/04/2024
5:12 AM
DiaMedica Therapeutics (Filer)
Form ARS
04/04/2024
5:05 AM
DiaMedica Therapeutics (Filer)
Form DEF 14A
04/04/2024
5:06 AM
DiaMedica Therapeutics (Filer)
Form DEFA14A
03/21/2024
3:47 PM
DiaMedica Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/23/2024
3:23 PM
DiaMedica Therapeutics (Issuer)
Lorianne Masuoka K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:00 PM
DiaMedica Therapeutics (Issuer)
Kuntz Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:05 PM
DiaMedica Therapeutics (Issuer)
Semba Charles Pauling (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:47 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:39 PM
DiaMedica Therapeutics (Issuer)
Parsons James T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:37 PM
DiaMedica Therapeutics (Issuer)
Wambeke David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DMAC) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners